Mismatch 'never events' in hip and knee arthroplasty: a cohort and intervention study.


Journal

The bone & joint journal
ISSN: 2049-4408
Titre abrégé: Bone Joint J
Pays: England
ID NLM: 101599229

Informations de publication

Date de publication:
08 2019
Historique:
entrez: 1 8 2019
pubmed: 1 8 2019
medline: 14 8 2019
Statut: ppublish

Résumé

The aim of this study was to give estimates of the incidence of component incompatibility in hip and knee arthroplasty and to test the effect of an online, real-time compatibility check. Intraoperative barcode registration of arthroplasty implants was introduced in Denmark in 2013. We developed a compatibility database and, from May 2017, real-time compatibility checking was implemented and became part of the registration. We defined four classes of component incompatibility: A-I, A-II, B-I, and B-II, depending on an assessment of the level of risk to the patient (A/B), and on whether incompatibility was knowingly accepted (I/II). A total of 26 524 arthroplasties were analyzed. From 12 307 procedures that were undertaken before implementation of the compatibility check, 21 class A incompatibilities were identified (real- or high-risk combinations; 0.17%; 95% confidence interval (CI) 0.11 to 0.26). From 5692 hip and 6615 knee procedures prior to implementation of the compatibility check, we found rates of class A-I incompatibility (real- or high-risk combinations unknowingly inserted) of 0.14% (95% CI 0.06 to 0.28) and 0.17% (95% CI 0.08 to 0.30), respectively. From 14 217 procedures after the introduction of compatibility checking (7187 hips and 7030 knees), eight class A incompatibilities (0.06%; 95% CI 0.02 to 0.11) were identified. This difference was statistically significant (p = 0.008). Our data presents validated estimates of the baseline incidence of incompatibility events for hip and knee arthroplasty procedures and shows that a significant reduction in class A incompatibility events is possible using a web-based recording system. Cite this article:

Identifiants

pubmed: 31362543
doi: 10.1302/0301-620X.101B8.BJJ-2018-1124.R1
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

960-969

Auteurs

A Odgaard (A)

Copenhagen University Hospital Herlev-Gentofte, Hellerup, Denmark.

M B Laursen (MB)

Aalborg University Hospital, Aalborg, Denmark.

K Gromov (K)

Copenhagen University Hospital Hvidovre, Hvidovre, Denmark.

A Troelsen (A)

Copenhagen University Hospital Hvidovre, Hvidovre, Denmark.

P W Kristensen (PW)

Vejle Hospital, Vejle, Denmark.

H Schrøder (H)

Næstved Hospital, Næstved, Denmark.

F Madsen (F)

Aarhus University Hospital, Aarhus, Denmark.

S Overgaard (S)

Odense University Hospital, Odense, Denmark.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH